A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice

Jiayi Pan(Central South University), Hui Liu(State Key Laboratory of Respiratory Disease), Zixuan Fang(Guangzhou Medical University), Jiashan He(Guangzhou Medical University), Yi Shi(Guangzhou Medical University), Bishi Fu(State Key Laboratory of Respiratory Disease), Maoping Huang(Guangzhou Medical University), Jun Dong(TEDA International Cardiovascular Hospital), Rong Zhang(First Affiliated Hospital of Bengbu Medical College), Danni Wang(Guangzhou Medical University), Bei Zhong(Guangzhou Medical University), Menghua He(Guangzhou Medical University), Xinyu Yang(Command Hospital), Wuyi Zeng(Guangzhou Medical University), Jiangtao Jia(Guangzhou Medical University)
Vaccines
July 8, 2022
Cited by 12


Related Papers